You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 26, 2024

Litigation Details for TAKATA v. RIOT BLOCKCHAIN, INC. (D.N.J. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Biologic Drugs cited in TAKATA v. RIOT BLOCKCHAIN, INC.
The biologic drug covered by the patent cited in this case is ⤷  Sign Up .

Details for TAKATA v. RIOT BLOCKCHAIN, INC. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2019-09-05 118 Exhibit I 28, 2028. The U.S. Patent for this family was granted in September 2014 (8,835,386) expiring November …WU's patent estate. This extensive portfolio consists of both patents and pending patent applications…Following the grant of the patent in 2011 by the European Patent Office, the patent was validated in the following…applications (approximately 25 patents and numerous patent applications) related to our animal health products… ends upon the expiration of the last patent to expire. Patents in the estate have expiration dates ranging External link to document
2021-02-08 196 Exhibit A 28, 2028. The U.S. Patent for this family was granted in September 2014 (8,835,386) expiring November …WU's patent estate. This extensive portfolio consists of both patents and pending patent applications…Following the grant of the patent in 2011 by the European Patent Office, the patent was validated in the …applications (approximately 25 patents and numerous patent applications) related to our animal health products… ends upon the expiration of the last patent to expire. Patents in the estate have expiration dates External link to document
2022-07-18 234 Exhibit A 28, 2028. The U.S. Patent for this family was granted in September 2014 (8,835,386) expiring November …WU's patent estate. This extensive portfolio consists of both patents and pending patent applications…Following the grant of the patent in 2011 by the European Patent Office, the patent was validated in the …applications (approximately 25 patents and numerous patent applications) related to our animal health products… ends upon the expiration of the last patent to expire. Patents in the estate have expiration dates External link to document
2019-03-18 67 Exhibit I 28, 2028. The U.S. Patent for this family was granted in September 2014 (8,835,386) expiring November …WU's patent estate. This extensive portfolio consists of both patents and pending patent applications…Following the grant of the patent in 2011 by the European Patent Office, the patent was validated in the following…applications (approximately 25 patents and numerous patent applications) related to our animal health products… ends upon the expiration of the last patent to expire. Patents in the estate have expiration dates ranging External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.